PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW
Prenetics Global Ltd
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2026
$19.02+0.50 (+2.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Prenetics Global statistics
Financials through Dec 31, 2024, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Market Cap | $320.95M | $164.85M |
| Enterprise Value | $269.65M | $87.06M |
| PS Ratio | 10.48 | 3.60 |
| PB Ratio | 1.88 | 2.03 |
| P/TBV Ratio | 2.64 | 2.31 |
Enterprise value
| Measure | Prenetics Global | Industry median |
|---|---|---|
| EV / Sales | 8.81 | 2.43 |
Income (trailing twelve months)
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Revenue | $30.62M | $57.94M |
| Gross Profit | $15.40M | $90.47M |
| Operating Income | -$48.14M | -$21.44M |
| Pretax Income | -$57.70M | -$14.45M |
| Net Income | -$46.30M | -$22.46M |
| EBITDA | -$48.14M | -$16.91M |
| EPS (Diluted) | -$3.71 | -$0.83 |
Margins
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Gross Margin | 50.3% | 52.3% |
| Operating Margin | -157.2% | -44.5% |
| Pretax Margin | -188.4% | -13.0% |
| Profit Margin | -151.2% | -39.2% |
| EBITDA Margin | -157.2% | -31.3% |
| FCF Margin | -97.6% | -8.85% |
Returns
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Return on Equity (ROE) | -27.2% | -53.1% |
| Return on Assets (ROA) | -21.7% | -41.0% |
| Return on Invested Capital (ROIC) | -32.2% | -32.0% |
| Return on Capital Employed (ROCE) | -27.2% | -37.8% |
Growth
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 40.8% | 6.01% |
| Revenue Growth (3Y CAGR) | 34.7% | 2.25% |
Balance sheet
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $52.25M | $62.42M |
| Net Cash (Debt) | $52.25M | $15.68M |
| Net Cash Per Share | $3.10 | $0.66 |
| Equity (Book Value) | $170.39M | $48.79M |
| Book Value Per Share | $10.10 | $1.36 |
| Tangible Book Value | $121.45M | $23.06M |
| Working Capital | $49.60M | $75.77M |
Financial position
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Current Ratio | 2.36 | 3.30 |
| Quick Ratio | 1.89 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Operating Cash Flow | -$28.87M | -$12.35M |
| Capital Expenditures | -$1.01M | -$1.06M |
| Free Cash Flow | -$29.88M | -$20.28M |
| FCF Per Share | -$1.77 | -$0.42 |
Efficiency
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Asset Turnover | 0.14 | 0.38 |
| Inventory Turnover | 2.32 | 2.67 |
| Revenue Per Employee | $312.46K | $398.96K |
| Profits Per Employee | -$472.49K | -$703.34K |
| Employee Count | 98 | 74 |
Dividends and yields
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Earnings Yield | -14.4% | -22.7% |
| FCF Yield | -9.31% | -9.07% |
Shares
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Shares Outstanding | 16,874,100 | 58,179,650 |
| Shares Change (YoY) | 11.1% | 11.1% |
| Float | 14,486,300 | 49,173,100 |
| Shares Held by Insiders | 14.2% | 11.6% |
Taxes
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Income Tax | -$7.87M | $91.50K |
Scores
| Measure | Prenetics Global | Industry median |
|---|---|---|
| Altman Z-Score | 4.24 | -0.24 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Prenetics Global's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.